Finance

Beta
Lists
9620:TADAWUL
Balsm Alofoq Medical Company CJSC
SAR 24.19
0.00%
(0.00) 1D
Jun 3, 1:59:59 PM GMT+3  ·   SAR
All symbols
SymbolPriceChange% Change
Generating top insights for 9620...
Mkt. cap
60.48M
Avg. vol.
273.00
Volume
0.00
P/E ratio
30.74
52-wk high
SAR 39.50
52-wk low
SAR 22.00
EPS
SAR 0.79
Shares outstanding
912.50K
No. of employees
81
Mkt. cap
60.48M
Avg. vol.
273.00
Volume
0.00
P/E ratio
30.74
52-wk high
SAR 39.50
52-wk low
SAR 22.00
EPS
SAR 0.79
Shares outstanding
912.50K
No. of employees
81
News stories
From sources across the web
About Balsm Alofoq Medical Company CJSC
CEO-
Employees81
Founded2012
Headquarters-
SectorHealth care provider
Previous reportsAll values in SAR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SAR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
4.88M
4.88M
5.31M
5.31M
Cost of goods sold
2.75M
2.75M
3.55M
3.55M
Cost of revenue
2.75M
2.75M
3.55M
3.55M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.40M
1.40M
1.25M
1.25M
Operating expense
1.42M
1.42M
1.22M
1.22M
Total operating expenses
4.17M
4.17M
4.77M
4.77M
Operating income
712.81K
712.81K
538.19K
538.19K
Other non operating income
18.92K
18.92K
-7.67K
-7.67K
EBT including unusual items
706.92K
706.92K
523.50K
523.50K
EBT excluding unusual items
706.92K
706.92K
523.50K
523.50K
Income tax expense
35.18K
35.18K
211.54K
211.54K
Effective tax rate
4.98%
4.98%
40.41%
40.41%
Other operating expenses
-
-
-
-
Net income
671.74K
671.74K
311.96K
311.96K
Net profit margin
13.77%
13.77%
5.88%
5.88%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-24.80K
-24.80K
-7.02K
-7.02K
Net interest expenses
-24.80K
-24.80K
-7.02K
-7.02K
Depreciation and amortization charges
-
-
-
-
EBITDA
942.97K
942.97K
769.86K
769.86K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more